Literature DB >> 31064884

Structural insights into the functional versatility of an FHA domain protein in mycobacterial signaling.

Tristan Wagner1, Gwénaëlle André-Leroux1, Valérie Hindie1, Nathalie Barilone1, María-Natalia Lisa1, Sylviane Hoos2, Bertrand Raynal2, Brigitte Vulliez-Le Normand1, Helen M O'Hare3, Marco Bellinzoni4, Pedro M Alzari4.   

Abstract

Forkhead-associated (FHA) domains are modules that bind to phosphothreonine (pThr) residues in signaling cascades. The FHA-containing mycobacterial protein GarA is a central element of a phosphorylation-dependent signaling pathway that redirects metabolic flux in response to amino acid starvation or cell growth requirements. GarA acts as a phosphorylation-dependent ON/OFF molecular switch. In its nonphosphorylated ON state, the GarA FHA domain engages in phosphorylation-independent interactions with various metabolic enzymes that orchestrate nitrogen flow, such as 2-oxoglutarate decarboxylase (KGD). However, phosphorylation at the GarA N-terminal region by the protein kinase PknB or PknG triggers autoinhibition through the intramolecular association of the N-terminal domain with the FHA domain, thus blocking all downstream interactions. To investigate these different FHA binding modes, we solved the crystal structures of the mycobacterial upstream (phosphorylation-dependent) complex PknB-GarA and the downstream (phosphorylation-independent) complex GarA-KGD. Our results show that the phosphorylated activation loop of PknB serves as a docking site to recruit GarA through canonical FHA-pThr interactions. However, the same GarA FHA-binding pocket targets an allosteric site on nonphosphorylated KGD, where a key element of recognition is a phosphomimetic aspartate. Further enzymatic and mutagenesis studies revealed that GarA acted as a dynamic allosteric inhibitor of KGD by preventing crucial motions in KGD that are necessary for catalysis. Our results provide evidence for physiological phosphomimetics, supporting numerous mutagenesis studies using such approaches, and illustrate how evolution can shape a single FHA-binding pocket to specifically interact with multiple phosphorylated and nonphosphorylated protein partners.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31064884     DOI: 10.1126/scisignal.aav9504

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  5 in total

1.  Allosteric regulation of menaquinone (vitamin K2) biosynthesis in the human pathogen Mycobacterium tuberculosis.

Authors:  Ghader Bashiri; Laura V Nigon; Ehab N M Jirgis; Ngoc Anh Thu Ho; Tamsyn Stanborough; Stephanie S Dawes; Edward N Baker; Esther M M Bulloch; Jodie M Johnston
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

2.  Deletion of pknG Abates Reactivation of Latent Mycobacterium tuberculosis in Mice.

Authors:  Mehak Zahoor Khan; Vinay Kumar Nandicoori
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

3.  Identifying RO9021 as a Potential Inhibitor of PknG from Mycobacterium tuberculosis: Combinative Computational and In Vitro Studies.

Authors:  Alicia Arica-Sosa; Roberto Alcántara; Gabriel Jiménez-Avalos; Mirko Zimic; Pohl Milón; Miguel Quiliano
Journal:  ACS Omega       Date:  2022-05-31

4.  In Silico Identification of Possible Inhibitors for Protein Kinase B (PknB) of Mycobacterium tuberculosis.

Authors:  Tatiana F Vieira; Fábio G Martins; Joel P Moreira; Tiago Barbosa; Sérgio F Sousa
Journal:  Molecules       Date:  2021-10-12       Impact factor: 4.411

5.  A Tetratricopeptide Repeat Scaffold Couples Signal Detection to OdhI Phosphorylation in Metabolic Control by the Protein Kinase PknG.

Authors:  María-Natalia Lisa; Adrià Sogues; Nathalie Barilone; Meike Baumgart; Magdalena Gil; Martín Graña; Rosario Durán; Ricardo M Biondi; Marco Bellinzoni; Michael Bott; Pedro M Alzari
Journal:  mBio       Date:  2021-10-05       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.